SCHEMBL6426658

SCHEMBL6426658

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc4c(c3)OC(F)(F)O4)cc2)ccn1.CNC(=O)c1cc(Oc2cccc(NC(=O)Nc3ccc4c(c3)OC(F)(F)O4)c2)ccn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.66
RET P07949 3/20 0.66
MAPK14 Q16539 3/20 0.66
SRC P12931 3/20 0.66
AURKB Q96GD4 3/20 0.66
HIPK4 Q8NE63 3/20 0.66
PLK4 O00444 2/20 0.66
AURKA O14965 2/20 0.66
MAPK13 O15264 2/20 0.66
MAP4K4 O95819 2/20 0.66
ABL1 P00519 2/20 0.66
LCK P06239 2/20 0.66
FYN P06241 2/20 0.66
LYN P07948 2/20 0.66
RPS6KB1 P23443 2/20 0.66
EPHA2 P29317 2/20 0.66
AXL P30530 2/20 0.66
FRK P42685 2/20 0.66
MAPK9 P45984 2/20 0.66
BLK P51451 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479637 0.97 RET (0.63) KDRRETMAPK14SRCAURKB
SCHEMBL6474265 0.95 RAF1 (0.66) KDRRETMAPK14SRCAURKB
SCHEMBL6387944 0.92 RET (0.63) KDRRETMAPK14SRCAURKB
SCHEMBL6384913 0.90 RAF1 (0.66) KDRRETMAPK14SRCAURKB
SCHEMBL6382324 0.87 RAF1 (0.65) KDRRETMAPK14SRCAURKB
SCHEMBL6385513 0.86 RAF1 (0.60) KDRRETMAPK14SRCAURKB
SCHEMBL6384112 0.86 RET (0.59) KDRRETMAPK14SRCAURKB
SCHEMBL6480098 0.86 RAF1 (0.60) KDRRETMAPK14SRCAURKB
SCHEMBL6381789 0.85 KDR (0.60) KDRRETMAPK14SRCAURKB
SCHEMBL5569372 0.85 KDR (0.74) KDRRETMAPK14SRCAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608639-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-28 EP claimed
WO-2004078748-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 WO claimed